tag:blogger.com,1999:blog-8940688823570157542.post6326814191519785608..comments2024-02-01T02:58:16.159-05:00Comments on Nephrology World: Reverse epidemiology in ESRD: DigoxinSridhar Reddy Allam, MD, MPHhttp://www.blogger.com/profile/10282191247397718857noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-8940688823570157542.post-6897987594029993112010-07-02T14:05:45.234-04:002010-07-02T14:05:45.234-04:00It can only be reverse epidemiology if the drug or...It can only be reverse epidemiology if the drug or attribute is good for the general public. I am unaware of any data showing better survival with dig. Am I missing something?<br /><br />See: The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. (Engl J Med 1997; 336:525-33.)Kidney_Boyhttps://www.blogger.com/profile/03706593315253399631noreply@blogger.com